IDiyas

For the Inventor, By the Inventor

Lawrenceville, NJ, United States of America

Christopher Blair Cooper

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 212(Granted Patents)


Location History:

  • Groton, CT (US) (2000)
  • Truckee, CA (US) (2001)
  • Los Angeles, CA (US) (2001)
  • Northridge, CA (US) (2014)
  • Lawrenceville, NJ (US) (2004 - 2021)
  • New York, NY (US) (2020 - 2024)

Company Filing History:

goldMedal5 out of 10 
 
Global Alliance for Tb Drug Development
 patents
silverMedal3 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents
bronzeMedal2 out of 4,455 
 
Pfizer Corporation
 patents
4. 2 out of 2,076 
 
Janssen Pharmaceutica Nv
 patents
5. 3 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2024

where 'Filed Patents' based on already Granted Patents

13 patents (USPTO):
1. 11964949 - Substituted phenyloxazolidinones for antimicrobial therapy (2024-04-23),
2. 10981891 - Antibacterial compounds and uses thereof (2021-04-20),
3. 10550092 - Substituted phenyloxazolidinones for antimicrobial therapy (2020-02-04),
4. 10508097 - Antibacterial compounds and uses thereof (2019-12-17),
5. 8716292 - Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity (2014-05-06),
6. 8695150 - Tablet computer cleaning device (2014-04-15),
7. 8148396 - Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors (2012-04-03),
8. 7579360 - Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors (2009-08-25),
9. 7459460 - Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators (2008-12-02),
10. 6720427 - Thiazole derivatives (2004-04-13),
11. 6295868 - Real-time snow load measuring system (2001-10-02),
12. 6176241 - System and method for cardiorespiratory conditioning (2001-01-23),
13. 6043238 - 2-Aminobenzazapine derivatives (2000-03-28),

Title: Christopher Blair Cooper: A Trailblazer in Innovation and Patent Development

Introduction:

Christopher Blair Cooper, a renowned inventor based in Lawrenceville, NJ, has carved a niche for himself in the world of patents and inventions. With a passion for innovation and a knack for solving complex problems, Cooper has earned a stellar reputation as a prominent figure in the industry.

Latest Patents:

Cooper's latest patents showcase his expertise in the field of pharmaceuticals and antimicrobial therapy. "Antibacterial compounds and uses thereof" focuses on formula (I) compounds for treating tuberculosis, while "Substituted phenyloxazolidinones for antimicrobial therapy" introduces novel oxazolidinones for combating microbial infections.

Career Highlights:

Having accumulated a total of 9 patents to his name, Cooper has made significant contributions to cutting-edge research and development. His work at the Global Alliance for Tuberculosis Drug Development and Bristol-Myers Squibb Company has been instrumental in shaping the landscape of medical innovation.

Collaborations:

Throughout his career, Cooper has collaborated with esteemed professionals in the field, including Zheming Ruan and Zhenkun Ma. These collaborations have led to groundbreaking discoveries and advancements in the realm of pharmaceuticals and healthcare.

Conclusion:

Christopher Blair Cooper's unwavering dedication to innovation and his exceptional talent as an inventor continue to inspire aspiring inventors around the globe. His work not only enhances the quality of healthcare but also paves the way for future generations to push the boundaries of what is possible in the world of patents and inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…